Manoj Kumar Panigrahi

Germline <em>BRCA1</em> and <em>BRCA2</em> deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India

Anurag Mehta, Smreti Vasudevan, Sanjeev Kumar Sharma et al. · Cancer Management and Research · 2018 · 40 citations · Full text

DNMT3A (R882) mutation features and prognostic effect in acute myeloid leukemia in Coexistent with NPM1 and FLT3 mutations

Dushyant Kumar, Anurag Mehta, Manoj Kumar Panigrahi et al. · Hematology/Oncology and Stem Cell Therapy · 2017 · 25 citations · Full text

Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape

Anurag Mehta, Smreti Vasudevan, Sanjeev Kumar Sharma et al. · Applied cancer research/Applied Cancer Research · 2020 · 19 citations · Full text

Pathology, Broad Testing, Tumor Biology +20

Detection of false positive mutations in BRCA gene by next generation sequencing

Moushumi Suryavanshi, Dushyant Kumar, Manoj Kumar Panigrahi et al. · Familial Cancer · 2016 · 17 citations

Next Generation, Sequencing, Engineering +13

<b><i>MET</i></b> Amplification and Response to MET Inhibitors in Stage IV Lung Adenocarcinoma

Moushumi Suryavanshi, Aekta Shah, Dushyant Kumar et al. · Oncology Research and Treatment · 2017 · 16 citations · Full text